Cervical cancer is the fourth most common cancer among women globally, with
approximately 580,000 new diagnoses in 2018. Approximately, 90% of deaths from this …

Abstract Treatment of preinvasive lesions is critical to the success of secondary prevention of
cervical cancer. In many settings, however, excision or ablation of preinvasive lesions can …

Precancerous cervical lesions precede the development of invasive cervical cancer by 10–
20 years, making cervical cancer preventable if these lesions are detected and effectively …

Human papillomavirus-associated anal and cervical cancers in... : Current Opinion in HIV
and AIDS Human papillomavirus-associated anal and cervical cancers in HIV-infected …

The risk of developing malignancy is higher in patients with human immunodeficiency virus
(HIV) infection than in non–HIV-infected patients. Several factors including …

Background Screening and treating premalignant cervical lesions (cervical intraepithelial
neoplasia 2+[CIN2+]) is an effective way to prevent cervical cancer, and recommendations …

Background Thermal coagulation is gaining popularity for treating cervical intraepithelial
neoplasia (CIN) in screening programs in low‐and middle‐income countries (LMICs) due to …

Thermal ablation is a point‐of‐care ablative treatment technique for cervical intraepithelial
neoplasia (CIN). However, limited information is available about its efficacy in low‐and …

Cervical cancer (CC) is a leading cause of cancer-related death and a major public health
issue in sub-Saharan Africa. This heavy burden parallels that of the human …

Cancer in women with HIV continues to be a major source of morbidity and mortality
worldwide, especially in low-income countries. Screening strategies, primary prevention …